2.4.0.8128 - Disclosure - Meda License, Development and Supply Agreements - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE71016---1310-Q0006_STD_92_20130630_0http://www.sec.gov/CIK0001103021duration2013-03-31T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE71016---1310-Q0006_STD_91_20120630_0http://www.sec.gov/CIK0001103021duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE71016---1310-Q0006_STD_181_20130630_0http://www.sec.gov/CIK0001103021duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE71016---1310-Q0006_STD_182_20120630_0http://www.sec.gov/CIK0001103021duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$eol_PE71016---1310-Q0006_STD_181_20130630_0_925123x1093898http://www.sec.gov/CIK0001103021duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseONSOLIS[Member]us-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_OnsolisMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDtruefalse$eol_PE71016---1310-Q0006_STD_182_20120630_0_925123x1093898http://www.sec.gov/CIK0001103021duration2012-01-01T00:00:002012-06-30T00:00:00falsefalseONSOLIS[Member]us-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_OnsolisMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$eol_PE71016---1310-Q0006_STD_31_20091031_0_923497x921516http://www.sec.gov/CIK0001103021duration2009-10-01T00:00:002009-10-31T00:00:00falsefalseUS [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldicountry_USus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$eol_PE71016---1310-Q0006_STD_181_20130630_0_923497x921516http://www.sec.gov/CIK0001103021duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseUS [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldicountry_USus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDtruefalse$eol_PE71016---1310-Q0006_STD_31_20121031_0_923497x924552http://www.sec.gov/CIK0001103021duration2012-10-01T00:00:002012-10-31T00:00:00falsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10false USDtruefalse$eol_PE71016---1310-Q0006_STD_181_20130630_0_923497x924552http://www.sec.gov/CIK0001103021duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false USDtruefalse$eol_PE71016---1310-Q0006_STD_366_20121231_0_923497x924552http://www.sec.gov/CIK0001103021duration2012-01-01T00:00:002012-12-31T00:00:00falsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12false USDtruefalse$eol_PE71016---1310-Q0006_STD_0_20130630_0_923497x924552_928294x1096019http://www.sec.gov/CIK0001103021instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseMilestones [Member]us-gaap_TypeOfArrangementAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_MilestonesMemberus-gaap_TypeOfArrangementAxisexplicitMemberfalsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13false USDtruefalse$eol_PE71016---1310-Q0006_STD_31_20121031_0_923497x924552_928294x1116900http://www.sec.gov/CIK0001103021duration2012-10-01T00:00:002012-10-31T00:00:00falsefalseMeda License Development and Supply Agreement [Member]us-gaap_TypeOfArrangementAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_MedaLicenseDevelopmentAndSupplyAgreementMemberus-gaap_TypeOfArrangementAxisexplicitMemberfalsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14false USDtruefalse$eol_PE71016---1310-Q0006_STD_31_20120531_0_923497x924552_925123x1093898_928294x1116900http://www.sec.gov/CIK0001103021duration2012-05-01T00:00:002012-05-31T00:00:00falsefalseMeda License Development and Supply Agreement [Member]us-gaap_TypeOfArrangementAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_MedaLicenseDevelopmentAndSupplyAgreementMemberus-gaap_TypeOfArrangementAxisexplicitMemberfalsefalseEU [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeanUnionMemberus-gaap_StatementGeographicalAxisexplicitMemberfalsefalseONSOLIS[Member]us-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_OnsolisMemberus-gaap_ProductOrServiceAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue Recognition, Multiple-deliverable Arrangements [Line Items]2false 4us-gaap_ContractsRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19089491908949USD$falsetruefalse2truefalsefalse1629797216297972USD$falsetruefalse3truefalsefalse35309263530926USD$falsetruefalse4truefalsefalse3280213732802137USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse5970000059700000USD$falsetruefalse8falsefalsefalse00falsefalsefalse9truefalsefalse1750000017500000USD$falsetruefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13truefalsefalse25000002500000USD$falsetruefalse14truefalsefalse25000002500000USD$falsetruefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Aggregate milestones and services revenue recognized3false 4us-gaap_DeferredRevenueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse14000001400000falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 false2Remaining deferred revenue related to the EU Media arrangement milestones4false 4us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognizedus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11truefalsefalse50000005000000falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of consideration recognized during the period for the milestone or milestones.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=19771982&loc=SL6892177-166501 false2Additional revenues in milestones5false 4bdsi_UpfrontPaymentOfResearchAndDevelopmentExpensesbdsi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse13100001310000falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse6000060000falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryUpfront payment of research and development expenses.No definition available.false2Estimated portion of upfront payments6false 4us-gaap_RoyaltyRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsepositiveLabel1truefalsefalse855101855101falsefalsefalse2falsefalsefalse00  falsefalsefalse3truefalsefalse855101855101falsefalsefalse4falsefalsefalse00  falsefalsefalse5truefalsefalse900000900000falsefalsefalse6truefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Product royalty revenues7false 4us-gaap_CostOfRevenueus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse690207690207USD$falsetruefalse2truefalsefalse375000375000USD$falsetruefalse3truefalsefalse10652071065207USD$falsetruefalse4truefalsefalse750000750000USD$falsetruefalse5truefalsefalse11000001100000USD$falsetruefalse6truefalsefalse800000800000USD$falsetruefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate cost of goods produced and sold and services rendered during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 false2Cost of product royalties8false 4bdsi_ShelfLifeOfProductbdsi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse0024 monthsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaShelf life of product.No definition available.false0Shelf life of the productfalseMeda License, Development and Supply Agreements - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.bdsi.com/taxonomy/role/DisclosureMedaLicenseDevelopmentAndSupplyAgreementsAdditionalInformation148